The present paper provides a brief overview of the rationale behind magnetic resonance imaging (MRI ... Multiple hepatocellular carcinoma (HCC) in a cirrhotic liver in (a) arterial phase spoiled ...

Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major ... are working to use ...

Liver biomarkers at baseline in addition to changes during follow-up are associated with cirrhosis and HCC in HDV.

The diagnostic tools in this field principally involve US, contrast-enhanced CT scan, and magnetic resonance imaging (MRI ... For solid lesions, HCC, fibrolamellar carcinoma, choriocarcinoma ...

Recently, significant progress has been made in the treatment of patients with advanced HCC. Two randomized, placebo-controlled, phase III trials have shown sorafenib, an oral multitarget ...

The following is a summary of “Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis,” published in the November ...

Other types include fibrolamellar HCC, cholangiocarcinoma, and angiosarcoma. • Secondary, or metastatic, liver cancers are ..

Of the treatment options available for patients with hepatocellular carcinoma (HCC), partial hepatectomy ... This study showed that CT or MRI detection of microscopic residual tumor post-RFA ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

Research suggests that the HSD17B13 rs72613567 variant may mitigate the harmful effects of PNPLA3 mutations in liver fibrosis and even reduce the risk of hepatocellular carcinoma (HCC ...